195 related articles for article (PubMed ID: 6326201)
1. The use of stable prostaglandins to investigate prostacyclin (PGI2)-binding sites and PGI2-sensitive adenylate cyclase in human platelet membranes.
Lombroso M; Nicosia S; Paoletti R; Whittle BJ; Moncada S; Vane JR
Prostaglandins; 1984 Feb; 27(2):321-33. PubMed ID: 6326201
[TBL] [Abstract][Full Text] [Related]
2. Interrelationships between PGE1 and PGI2 binding and stimulation of adenylate cyclase.
Garrity MJ; Westcott KR; Eggerman TL; Andersen NH; Storm DR; Robertson RP
Am J Physiol; 1983 Apr; 244(4):E367-72. PubMed ID: 6132556
[TBL] [Abstract][Full Text] [Related]
3. (5Z)-carbacyclin discriminates between prostacyclin-receptors coupled to adenylate cyclase in vascular smooth muscle and platelets.
Corsini A; Folco GC; Fumagalli R; Nicosia S; Noe MA; Oliva D
Br J Pharmacol; 1987 Jan; 90(1):255-61. PubMed ID: 3545351
[TBL] [Abstract][Full Text] [Related]
4. 6-Keto-prostaglandin E1-sensitive adenylate cyclase and binding sites in membranes from platelets and cultured smooth muscle cells.
Oliva D; Bernini F; Corsini A; Nicosia S
Biochem Pharmacol; 1984 Dec; 33(23):3755-8. PubMed ID: 6391491
[TBL] [Abstract][Full Text] [Related]
5. Functional and ligand binding studies suggest heterogeneity of platelet prostacyclin receptors.
Armstrong RA; Lawrence RA; Jones RL; Wilson NH; Collier A
Br J Pharmacol; 1989 Jul; 97(3):657-68. PubMed ID: 2474350
[TBL] [Abstract][Full Text] [Related]
6. Epoprostenol (prostacyclin, PGI2) binding and activation of adenylate cyclase in platelets of diabetic and control subjects.
Shepherd GL; Lewis PJ; Blair IA; de Mey C; MacDermot J
Br J Clin Pharmacol; 1983 Jan; 15(1):77-81. PubMed ID: 6342639
[TBL] [Abstract][Full Text] [Related]
7. Novel mechanism of heterologous desensitization of adenylate cyclase: prostaglandins bind with different affinities to both stimulatory and inhibitory receptors on platelets.
Ashby B
Mol Pharmacol; 1990 Jul; 38(1):46-53. PubMed ID: 1695318
[TBL] [Abstract][Full Text] [Related]
8. (5Z)-carbacyclin displays agonist-antagonist properties on prostacyclin-receptors in platelets and vascular myocytes.
Corsini A; Oliva D; Folco GC; Giovanazzi S; Noe' MA; Fumagalli R; Nicosia S
Biomed Biochim Acta; 1988; 47(10-11):S104-7. PubMed ID: 3073757
[TBL] [Abstract][Full Text] [Related]
9. Prostaglandin endoperoxide analogues which are both thromboxane receptor antagonists and prostacyclin mimetics.
Armstrong RA; Jones RL; MacDermot J; Wilson NH
Br J Pharmacol; 1986 Mar; 87(3):543-51. PubMed ID: 3026540
[TBL] [Abstract][Full Text] [Related]
10. Prostacyclin (PGI) receptor binding and cyclic AMP synthesis activities of PGI1 analogues, SM-10906 and its methyl ester, SM-10902, in mastocytoma P-815 cells.
Oka M; Negishi M; Yamamoto T; Satoh K; Hirohashi T; Ichikawa A
Biol Pharm Bull; 1994 Jan; 17(1):74-7. PubMed ID: 7511960
[TBL] [Abstract][Full Text] [Related]
11. The binding of 6-oxo-prostaglandin E1 to platelet prostanoid receptors.
Jaschonek K; Renn W; Weisenberger H
Prostaglandins Leukot Med; 1986 Sep; 24(1):79-86. PubMed ID: 3020591
[TBL] [Abstract][Full Text] [Related]
12. Binding to prostaglandin (PG) receptors and activation of adenyl cyclase by 20-isopropylidene-PGS in rabbit platelet membranes.
Ushiyama S; Handa S; Yamazaki M
Prostaglandins; 1988 Oct; 36(4):477-89. PubMed ID: 2853419
[TBL] [Abstract][Full Text] [Related]
13. Refractoriness of platelets to prostaglandins after infusion in rabbits.
Bertelé V; Stemerman M; Schafer A; Adelman B; Smith M; Fuhro R; Salzman E
J Lab Clin Med; 1985 Nov; 106(5):551-61. PubMed ID: 2997353
[TBL] [Abstract][Full Text] [Related]
14. Heparin does not interfere with prostacyclin and prostaglandin D2 binding to platelets.
Fortini A; Modesti PA; Abbate R; Gensini GF; Neri Serneri GG
Thromb Res; 1985 Nov; 40(3):319-28. PubMed ID: 3001968
[TBL] [Abstract][Full Text] [Related]
15. Effects of heparin on prostacyclin binding and platelet adenylate cyclase activity stimulated by iloprost and forskolin.
Jaschonek K; Faul C; Daiss W; Weisenberger H
Prostaglandins Leukot Med; 1986 Oct; 24(2-3):199-206. PubMed ID: 2432618
[TBL] [Abstract][Full Text] [Related]
16. Effects of PGI2 on platelet aggregation and adenylate cyclase activity in human type IIa hypercholesterolemia.
Colli S; Lombroso M; Maderna P; Tremoli E; Nicosia S
Biochem Pharmacol; 1983 Jul; 32(13):1989-93. PubMed ID: 6347202
[TBL] [Abstract][Full Text] [Related]
17. Biochemical evidence for PGI2 and PGE2 receptors in the rabbit renal preglomerular microvasculature.
Chaudhari A; Gupta S; Kirschenbaum MA
Biochim Biophys Acta; 1990 Jul; 1053(2-3):156-61. PubMed ID: 2166584
[TBL] [Abstract][Full Text] [Related]
18. Specific binding of the new stable epoprostenol analogue beraprost sodium to prostacyclin receptors on human and rat platelets.
Kajikawa N; Nogimori K; Murata T; Nishio S; Uchiyama S
Arzneimittelforschung; 1989 Apr; 39(4):495-9. PubMed ID: 2665758
[TBL] [Abstract][Full Text] [Related]
19. Separate receptors for prostacyclin and prostaglandin E2 on human gel-filtered platelets.
Eggerman TL; Andersen NH; Robertson RP
J Pharmacol Exp Ther; 1986 Mar; 236(3):568-73. PubMed ID: 2869139
[TBL] [Abstract][Full Text] [Related]
20. Evidence for distinct prostaglandin I2 and D2 receptors in human platelets.
Miller OV; Gorman RR
J Pharmacol Exp Ther; 1979 Jul; 210(1):134-40. PubMed ID: 221643
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
